Joshua M Sharfstein
Biographic Data
| ID | 4485470 |
|---|---|
| NAME | Joshua M Sharfstein |
| GIVEN NAMES | Joshua M |
| FAMILY NAME | Sharfstein |
| SIGNATURE | SHARFSTEIN J M |
| AFFILIATIONS | Johns Hopkins University |
| ORCID | 0000-0003-0036-6785 |
| VERIFIED | Yes |
| TOTAL WORKS | 42 |
| TOTAL CITATIONS | 9 |
| AUTHOR COUNT | 42 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1998 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Cracks in the Foundation
BACKGROUND: Poor physical conditions of school facilities are linked to poor health, lower test scores, and higher rates of chronic absenteeism. METHODS: We conducted a cross-sectional analysis using data on physical conditions of school facilities, absenteeism, and test scores for 1266 K-12 school facilities representing 1388 schools (which may share school facilities) in Maryland. We analyzed the results by race and ethnicity of students and by…
Information Sick
Hidden Within the Structure
This article addresses disparities in school building conditions and repair within the state of Maryland, drawing particular attention to how the state maintenance funding formula systematically disadvantages the Baltimore school system, the state's system with the highest proportion of African American learners. We highlight the profound impacts of school infrastructure on students’ educational experiences and outcomes, particularly attendance a…
Vaccines and the 2024 US Presidential Election
This survey study reports on the vaccine-related views of voters surveyed soon after the 2024 US presidential election
Establishing Community Networks to Support Routine Vaccination
This JAMA Forum discusses vaccine hesitancy across communities in the US and provides examples of successful partnerships during the COVID-19 pandemic that could be incorporated and made more permanent
Recognizing and Strengthening the 4 Pillars of US Childhood Vaccine Policy
This JAMA Forum discusses Trump administration nominations for the secretary of the Department of Health and Human Services and the director of the Centers for Disease Control and Prevention, their positions on childhood vaccines, and provides information on the 4 pillars of the US childhood vaccine effort
The Value of Engagement and Transparency in Public Health Policymaking
This JAMA Forum discusses the importance of engagement and transparency in public health policy in the context of the US response to the COVID-19 pandemic and the recent dismissal of the Advisory Committee on Immunization Practices
Early Recalls and Clinical Validation Gaps in Artificial Intelligence–Enabled Medical Devices
This cross-sectional study examines whether lack of clinical validation and publicly traded manufacturer status were associated with recalls of artificial intelligence–enabled medical devices that had been cleared by the US Food and Drug Administration
The Domestic Consequences of Defunding Global Health
This JAMA Forum discusses the recent funding cuts to the United States Agency for International Development (USAID) and the potential ramifications of these cuts on global health and the health of individuals in the US
Advancing a National Infrastructure for Clinical Trials
This Viewpoint discusses improving clinical trials by modeling future research after clinical trials overseen by the National Cancer Institute, prioritizing cooperation between institutions, creating an infrastructure to answer multiple research questions, and integrating governance to determine key questions for research
The Role for Policy in AI-Assisted Medical Diagnosis
This JAMA Forum discusses the promise and pitfalls of using large language models and artificial intelligence (AI) in the diagnosis of patients
Unwinding Medicaid Eligibility
This JAMA Forum discusses 5 consequences of disenrolling individuals from Medicaid after the end of the pause in checking eligibility that was enacted during the emergency phase of the COVID-19 pandemic
The Case of the Disappearing Thank Yous
This JAMA Forum discusses declining time and space for appreciation of what has been accomplished in clinical medicine and health policy
Data on the US Economy—A Model for Health Data
This JAMA Forum discusses 3 key steps for restructuring the acquisition of health data to enable more timely access to the data and more timely public health action, similar to the successes seen with the COVID-19 pandemic response in the US
The Opioid Settlements—Will the First Steps Be in the Right Direction
This JAMA Forum discusses ways the opioid settlement funds could be used to save lives today and in the future, aspects of the decisions surrounding funding, and the importance of measuring progress
US Community Pharmacies and Public Health—Building on the Covid-19 Response
This JAMA Forum discusses the ways that US community pharmacies can build on the flexibility during the COVID-19 response to care for patients with HIV, hypertension, and opioid use disorder and improve access to reproductive health care
The Public Health Fixes That Missed the Omnibus
This JAMA Forum discusses the $1.7 trillion omnibus bill passed in December 2022 and the areas of pandemic preparedness and the public health system it addresses and misses
The Public Health Crisis Survival Guide
Firefighters fight fires. Police officers race to crime scenes, sirens blaring. And health officials? Health officials respond to crises. There are infectious disease crises, budget crises, environmental health crises, human resources crises—and many more. At such critical moments, what happens next really matters. A strong response can generate greater credibility and authority for a health agency and its leadership, while a bungled response can…
Battling Falsehoods in the Covid-19 Pandemic
Hello, doctor, I was calling to find out if the new variant
The New US National Biodefense Strategy—Necessary but Not Sufficient
This JAMA Forum discusses the Biden administration’s recently released National Biodefense Strategy and recommends that the implementation of this national strategy be accompanied by recommendations from the Commonwealth Fund Commission
Sharing the Media Spotlight—Communicating About Medical Products in Development During the Pandemic
In October, Merck & Co announced that its antiviral drug molnupiravir reduced the risk of severe COVID-19 by half, leading to a halt in study enrollment. The company's vice president of research told the news media, "When you see a 50 percent reduction in hospitalization or death, that's a substantial clinical impact
The Supreme Court’s New Direction and the Public’s Health
Within a few months, the US Supreme Court has eliminated the right to terminate a pregnancy, expanded the right to carry a gun, restricted the ability of the US Environmental Protection Agency to reduce power plant emissions, and stopped the Occupational Safety and Health Administration from protecting workers from COVID-19. These cases are likely to have severe and lasting consequences, exposing US residents to higher rates of maternal mortality…
Public Health Crisis Survival Guide
Extreme Risk Protection Orders—A Tool for Clinicians to Prevent Gun Violence
Recent, widely publicized mass shootings in Atlanta, Georgia
What the American Rescue Plan Means for Health Equity
The primary goal of the $1.9 trillion American Rescue Plan Act of 2021 is to help the nation recover from economic, health, and social devastation of the COVID-19 pandemic. Yet the law will accomplish even more. Many of the provisions will have important implications for health equity among communities of color and other disadvantaged groups
Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
Objectives. We examined the association between the expansion of methadone and buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore, Maryland from 1995 to 2009. Methods. We conducted a longitudinal time series analysis of archival data using linear regression with the Newey–West method to correct SEs for heteroscedasticity and autocorrelation, adjusting for average heroin purity. Results. Overdose deaths attributed to…
Critical Drugs for Critical Care
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis Mariana P. Socal MD, PhD, Joshua M. Sharfstein MD, and Jeremy A. Greene MD, PhD Affiliation Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy A. Greene is with the Department of History of Medicine and the Center for Medical Humanities …
Standard Death Certificates Versus Enhanced Surveillance to Identify Heroin Overdose–Related Deaths
Objectives. To compare 2 approaches to identifying heroin-related deaths in cases of overdose: standard death certificates and enhanced surveillance. Methods. We reviewed Maryland death certificates from 2012 to 2015 in cases of overdose to determine specific mentions of heroin. Counts were compared with estimates obtained through an enhanced surveillance approach that included a protocol considering cause of death, toxicology, and scene investig…
Congressional campaign priorities of the AMA
OBJECTIVES: This study sought to determine whether the political action committee of the American Medical Association (AMA) contributed more to pro- or anti-tobacco members of Congress in the 1995/96 campaign and whether representatives' voting records on malpractice reform could explain the AMA's contribution patterns. METHODS: Campaign contributions to House members were analyzed. RESULTS: The AMA's political action committee contributed averag…
Congressional campaign priorities of the AMA
OBJECTIVES: This study sought to determine whether the political action committee of the American Medical Association (AMA) contributed more to pro- or anti-tobacco members of Congress in the 1995/96 campaign and whether representatives' voting records on malpractice reform could explain the AMA's contribution patterns. METHODS: Campaign contributions to House members were analyzed. RESULTS: The AMA's political action committee contributed averag…
Blowing smoke
Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive "We show that the FDA is wrong on key factual and scientific points. Our comments review the many flaws in and evidence contradicting the FDA's allegations regarding such matters as tobacco growing, cigarette manufacturing and addiction
Smoking behaviours and attitudes among male restaurant workers in Boston's Chinatown
Despite high rates of smoking, Chinese American restaurant workers were generally aware of the health risks and were interested in quitting. Community based research can set the stage for targeted public health efforts to reduce smoking in immigrant communities
Research and Action in Urban Tobacco Control
Progress in Community Health Partnerships: Research, Education, and Action - Volume 3, Issue 1, Spring 2009
Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009
Objectives. We examined the association between the expansion of methadone and buprenorphine treatment and the prevalence of heroin overdose deaths in Baltimore, Maryland from 1995 to 2009. Methods. We conducted a longitudinal time series analysis of archival data using linear regression with the Newey–West method to correct SEs for heteroscedasticity and autocorrelation, adjusting for average heroin purity. Results. Overdose deaths attributed to…
Schwartz et al. Respond
As reported in our recent article, which found an association between expansion of methadone and buprenorphine treatment and the reduction in heroin overdose deaths in Baltimore, Maryland, between 1995 and 2009, the distribution of the opioid antagonist naloxone is one of a number of public health strategies being employed in the United States and United Kingdom (among other countries) to reduce opioid overdose deaths.1–4 From 2004 through 2009, …
US Hospital Awards and Community Health Improvement
AffiliationsMichael K. Poku is with Johns Hopkins Hospital, Baltimore, MD. Alexander B. Blum is with Aledade Inc, Bethesda, MD. Joshua M. Sharfstein is with the Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore
The Public Health Crisis Survival Guide
Firefighters fight fires. Police officers race to crime scenes, sirens blaring. And health officials? Health officials respond to crises. There are infectious disease crises, budget crises, environmental health crises, human resources crises—and many more. At such critical moments, what happens next really matters. A strong response can generate greater credibility and authority for a health agency and its leadership, while a bungled response can…
Crisis Management
A useful management approach for responding to crises is the incident command system. Developed in the 1970s to coordinate efforts at the scenes of fires and other disasters, incident command is now the standard management structure recommended for a broad range of disasters by the Federal Emergency Management Agency. Key attributes of incident command include clear leadership, specified roles, and management by objective. Once an agency has deve…
Recognizing a Crisis
The first order of business in crisis management is figuring out that there is a crisis. Once a brewing crisis is recognized, health officials can organize a coherent response, limit its impact, and even make an early pivot to achieve long-lasting change. Unfortunately, spotting a crisis early is far easier said than done. It’s the rare crisis that announces itself with a phone call 12 hours in advance. Most crises go unnoticed even as clues emer…
Standard Death Certificates Versus Enhanced Surveillance to Identify Heroin Overdose–Related Deaths
Objectives. To compare 2 approaches to identifying heroin-related deaths in cases of overdose: standard death certificates and enhanced surveillance. Methods. We reviewed Maryland death certificates from 2012 to 2015 in cases of overdose to determine specific mentions of heroin. Counts were compared with estimates obtained through an enhanced surveillance approach that included a protocol considering cause of death, toxicology, and scene investig…
How Not to Spend an Opioid Settlement
This Level of Death, It’s New”—Health Care Workers in Their Own Words
Unexpected Health Insurance Profits and the Covid-19 Crisis
The coronavirus disease 2019 (COVID-19) pandemic has placed unprecedented financial stress on most of the US health care system, including physician practices, emergency medical service systems, and hospitals. But there is one notable exception: health insurance companies. Sharp declines in elective care during the pandemic have reduced health care expenditures and contributed to earnings that are twice as large as those earned last year. For exa…
Critical Drugs for Critical Care
Critical Drugs for Critical Care: Protecting the US Pharmaceutical Supply in a Time of Crisis Mariana P. Socal MD, PhD, Joshua M. Sharfstein MD, and Jeremy A. Greene MD, PhD Affiliation Mariana P. Socal and Joshua M. Sharfstein are with the Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD. Jeremy A. Greene is with the Department of History of Medicine and the Center for Medical Humanities …
Extreme Risk Protection Orders—A Tool for Clinicians to Prevent Gun Violence
Recent, widely publicized mass shootings in Atlanta, Georgia
What the American Rescue Plan Means for Health Equity
The primary goal of the $1.9 trillion American Rescue Plan Act of 2021 is to help the nation recover from economic, health, and social devastation of the COVID-19 pandemic. Yet the law will accomplish even more. Many of the provisions will have important implications for health equity among communities of color and other disadvantaged groups
Child Health Policy and the Covid-19 Pandemic
An axiom of pediatrics is that children are not just small adults. In his first presidential address to the American Pediatric Society in 1889, Abraham Jacobi, MD, declared: "Pediatrics does not deal with miniature men and women, with reduced doses and the same classes of diseases in smaller bodies, butit has its own independent range and horizon." 1 This concept should extend to health policy for children, who deserve much more than efforts desi…
The Pandemic and the Supply Chain
The Public Health Crisis Survival Guide
Firefighters fight fires. Police officers race to crime scenes, sirens blaring. And health officials? Health officials respond to crises. There are infectious disease crises, budget crises, environmental health crises, human resources crises—and many more. At such critical moments, what happens next really matters. A strong response can generate greater credibility and authority for a health agency and its leadership, while a bungled response can…
Battling Falsehoods in the Covid-19 Pandemic
Hello, doctor, I was calling to find out if the new variant
The New US National Biodefense Strategy—Necessary but Not Sufficient
This JAMA Forum discusses the Biden administration’s recently released National Biodefense Strategy and recommends that the implementation of this national strategy be accompanied by recommendations from the Commonwealth Fund Commission
Sharing the Media Spotlight—Communicating About Medical Products in Development During the Pandemic
In October, Merck & Co announced that its antiviral drug molnupiravir reduced the risk of severe COVID-19 by half, leading to a halt in study enrollment. The company's vice president of research told the news media, "When you see a 50 percent reduction in hospitalization or death, that's a substantial clinical impact
The Supreme Court’s New Direction and the Public’s Health
Within a few months, the US Supreme Court has eliminated the right to terminate a pregnancy, expanded the right to carry a gun, restricted the ability of the US Environmental Protection Agency to reduce power plant emissions, and stopped the Occupational Safety and Health Administration from protecting workers from COVID-19. These cases are likely to have severe and lasting consequences, exposing US residents to higher rates of maternal mortality…
Public Health Crisis Survival Guide
Medicine (30 works) · Political science (20 works) · Business (19 works) · Law (12 works) · Public health (11 works) · Computer Science (10 works) · Coronavirus disease 2019 (COVID-19 (10 works) · Nursing (10 works) · Environmental health (9 works) · Law (9 works)